Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia

@article{Nakamura2016SwitchingTF,
  title={Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia},
  author={Kensuke Nakamura and Ryota Inokuchi and Takahiro Hiruma and Kurato Tokunaga and Kent Doi and Susumu Nakajima},
  journal={Journal of Anesthesia},
  year={2016},
  volume={30},
  pages={891-894}
}
Beta-blockers are important for severe-status patients with atrial fibrillation-related tachycardia. Beta 1-selective intravenous injection are routinely used, but long-term administration is difficult due to cost-performance- or management-related issues. A bisoprolol patch, a beta-blocker to be percutaneously absorbed, recently became commercially available in Japan. As it may facilitate effective absorption and a mild elevation of the blood concentration, we retrospectively analyzed 16… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

Perioperative betablockade , discontinuation , and complications : do you really know it when you see it ?

MJ London
  • Anesthesi - ology
  • 2013

Similar Papers

Loading similar papers…